Business
Appointment of Non-Executive Director
Appointment of Non-Executive Director.
About this update from Futura Medical Plc
[{"type":"text","content":"\n \nRNS Number : 1501R Futura Medical PLC 07 March 2016 \n\n\n\n\n\nFor immediate release \n\n\n7 March 2016\n\n\n\n\n \n \nFutura Medical plc\n(\"Futura\" or the \"Company\")\n \nAppointment of Non-Executive Director\n \n \nFutura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce the appointment of Ken James, the former head of consumer healthcare R&D at GlaxoSmithKline plc (\"GSK\"), as a Non-Executive Director, with effect from 31 March 2016. \n \nMr James has more than 40 years' experience of healthcare R&D, having joined one of GSK's predecessor businesses, Beecham Products, in 1973. In 2006, he was appointed as Senior Vice President, GSK Consumer Healthcare R&D, with worldwide responsibility for consumer healthcare R&D, including medical and regulatory affairs and R&D sites spanning the globe. Mr James, who recently retired from his role at GSK, has a proven track record, having brought over 200 innovative consumer healthcare products to market across multiple geographies whilst heading GSK Consumer Healthcare R&D. \n \nCommenting on his appointment to Futura Medical, Ken James said: \"I have always believed that scientific differentiation is a clear point of competitive advantage in the consumer healthcare sector. In Futura, I see a company with good technology and a product portfolio with considerable potential. I look forward to bringing to Futura my 40-plus years' experience in the commercialisation of healthcare products.\"\n \nJames Barder, Futura Medical's Chief Executive, said: \"I am delighted to welcome Ken James to Futura's Board as a Non-Executive Director. As the former head of R&D at GSK consumer healthcare, his experience of the development and commercialisation of over-the-counter and consumer products is unparalleled. We very much look forward to his contribution to Futura.\"\n \nAdditional information:\n \nKenneth William James, aged 63 years, holds no shares in Futura. There are no further disclosures to be made in relation to Mr James under Schedule Two paragraphs (g) and (i) or Rule 17 of the AIM rules.\n \n \n \nFor further information please contact:\n\n\n\n\nFutura Medical plc\n\n\n\n\n\n\n\nJames Barder, Chief Exec...